B.O.S.S. Retirement Advisors LLC Purchases Shares of 16,910 Agilent Technologies, Inc. (NYSE:A)

B.O.S.S. Retirement Advisors LLC purchased a new position in Agilent Technologies, Inc. (NYSE:A) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 16,910 shares of the medical research company’s stock, valued at approximately $2,033,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Sumitomo Mitsui DS Asset Management Company Ltd boosted its position in shares of Agilent Technologies by 7.9% in the first quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 25,064 shares of the medical research company’s stock worth $3,467,000 after purchasing an additional 1,832 shares during the period. CIBC Asset Management Inc boosted its position in shares of Agilent Technologies by 2.0% in the first quarter. CIBC Asset Management Inc now owns 43,691 shares of the medical research company’s stock worth $6,044,000 after purchasing an additional 844 shares during the period. Sei Investments Co. boosted its position in shares of Agilent Technologies by 1.7% in the fourth quarter. Sei Investments Co. now owns 493,294 shares of the medical research company’s stock worth $73,824,000 after purchasing an additional 8,123 shares during the period. Empirical Finance LLC boosted its position in shares of Agilent Technologies by 4.1% in the first quarter. Empirical Finance LLC now owns 8,369 shares of the medical research company’s stock worth $1,158,000 after purchasing an additional 328 shares during the period. Finally, Mitsubishi UFJ Trust & Banking Corp lifted its position in shares of Agilent Technologies by 1.6% in the fourth quarter. Mitsubishi UFJ Trust & Banking Corp now owns 222,679 shares of the medical research company’s stock valued at $33,324,000 after acquiring an additional 3,409 shares in the last quarter.

Analyst Ratings Changes

A has been the topic of several research analyst reports. TD Cowen boosted their price objective on Agilent Technologies from $145.00 to $147.00 and gave the company an “outperform” rating in a research report on Wednesday, August 16th. Robert W. Baird reduced their price objective on shares of Agilent Technologies from $144.00 to $140.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 16th. TheStreet cut shares of Agilent Technologies from a “b” rating to a “c+” rating in a research report on Tuesday, August 15th. Stifel Nicolaus reduced their price objective on shares of Agilent Technologies from $153.00 to $135.00 and set a “hold” rating on the stock in a research report on Wednesday, May 24th. Finally, SVB Securities cut their price objective on Agilent Technologies from $170.00 to $145.00 and set an “outperform” rating for the company in a research report on Wednesday, May 24th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $148.12.

Insider Buying and Selling

In other news, CEO Michael R. Mcmullen sold 944 shares of the business’s stock in a transaction dated Thursday, July 27th. The stock was sold at an average price of $130.00, for a total transaction of $122,720.00. Following the sale, the chief executive officer now owns 260,869 shares in the company, valued at $33,912,970. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, VP Rodney Gonsalves sold 3,500 shares of the firm’s stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $118.78, for a total value of $415,730.00. Following the completion of the transaction, the vice president now directly owns 24,219 shares in the company, valued at $2,876,732.82. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Michael R. Mcmullen sold 944 shares of the firm’s stock in a transaction dated Thursday, July 27th. The stock was sold at an average price of $130.00, for a total value of $122,720.00. Following the completion of the transaction, the chief executive officer now owns 260,869 shares of the company’s stock, valued at $33,912,970. The disclosure for this sale can be found here.

Agilent Technologies Trading Up 0.9 %

Shares of A stock traded up $1.03 during trading hours on Friday, reaching $115.91. 6,889,629 shares of the stock were exchanged, compared to its average volume of 1,780,097. Agilent Technologies, Inc. has a 12-month low of $109.00 and a 12-month high of $160.26. The company has a current ratio of 2.29, a quick ratio of 1.68 and a debt-to-equity ratio of 0.49. The company’s 50-day moving average price is $121.63 and its 200-day moving average price is $126.83. The firm has a market capitalization of $33.91 billion, a price-to-earnings ratio of 30.36, a price-to-earnings-growth ratio of 2.09 and a beta of 1.03.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Tuesday, August 15th. The medical research company reported $1.43 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.07. Agilent Technologies had a net margin of 16.20% and a return on equity of 29.86%. The firm had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.66 billion. During the same period in the previous year, the company earned $1.34 EPS. The firm’s revenue for the quarter was down 2.7% compared to the same quarter last year. As a group, equities analysts anticipate that Agilent Technologies, Inc. will post 5.42 earnings per share for the current year.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.